Need For Improved Skin Cancer Surveillance in Pediatric Cancer Survivors
- 145 Downloads
Survivors of pediatric cancer are at increased risk of developing secondary malignancies, with non-melanoma skin cancer being the most common. These patients are also at increased risk of melanoma. Currently, guidelines provided by the National Cancer Institute and Children’s Oncology Group emphasize the importance of annual clinical examination for skin cancer screening; however, the literature reports that less than one-third of survivors of pediatric cancer have ever had a clinical skin exam by a physician. In this article, we review the risk factors for skin cancer in survivors of pediatric cancer as well as the current evidence and recommendations for their care. We suggest that dermatologists collectively establish guidelines for skin cancer surveillance in survivors of pediatric cancer.
Compliance with Ethical Standards
No sources of funding were used to conduct this study or prepare this manuscript.
Conflict of interest
The authors have no conflicts of interest that are directly relevant to the content of this article.
- 7.Curtis RE, Metayer C, Rizzo JD, Socie G, Sobocinski KA, Flowers ME, et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood. 2005;105(10):3802–11.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S, et al. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol. 2014;25(2):435–41.CrossRefPubMedGoogle Scholar
- 20.Baldwin S, Au S. One-year review of the SCREEN (Skin Cancer Post-Transplant) Clinic: what we have learned. J Cutan Med Surg. 2016. https://www.ncbi.nlm.nih.gov/pubmed/27663613.
- 22.Transplantation EEGoR. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment. Nephrol Dial Transpl. 2002;17(Suppl 4):31–6.Google Scholar
- 23.Late Effects of Treatment for Childhood Cancer (PDQ®). http://www.cancer.gov/cancertopics/pdq/treatment/lateeffects/Patient/page2. Accessed 15 Aug 2016.
- 25.Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers, Version 3.0. http://www.survivorshipguidelines.org/. Accessed 15 Aug 2016.
- 26.Detect skin cancer. https://www.aad.org/public/spot-skin-cancer/learn-about-skin-cancer/detect. Accessed 15 Aug 2016.
- 27.Basal Cell Carcinoma: Who Gets and Causes. https://www.aad.org/public/diseases/skin-cancer/basal-cell-carcinoma#causes. Accessed 15 Aug 2016.
- 29.Force USPST, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Ebell M, et al. Screening for skin cancer: US preventive services task force recommendation statement. JAMA. 2016;316(4):429–35.Google Scholar
- 31.Greenberg JN, Zwald FO. Management of skin cancer in solid-organ transplant recipients: a multidisciplinary approach. Dermatol Clin. 2011;29(2):231–41, ix.Google Scholar